1. E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA‐107 to augment progression of glioma
   Huan Xie et al, 2021, Brain and Behavior CrossRef
2. Clinical implications of serum miR-34a in breast cancer and its predictive value for the efficacy of neoadjuvant chemotherapy
   Yanyan Hong, 2024, American Journal of Translational Research CrossRef
3. E2F3 accelerates the stemness of colon cancer cells by activating the STAT3 pathway
   Qingkun Gao et al, 2023, Frontiers in Oncology CrossRef
4. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene
   Shaymaa M. M. Yahya et al, 2024, Breast Cancer Research and Treatment CrossRef
5. Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis
   Yao Yu et al, 2024, BioMed Research International CrossRef
6. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells
   Mohd Shuaib et al, 2024, Biomolecular Concepts CrossRef
7. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
   Rui Han et al, 2021, Scientific Reports CrossRef